Julie Saiki, Ph.D.
Equibles does not estimate personal net worth.
Get an email with a short summary when Azora Therapeutics, Inc. (DE) publishes a filing, an earnings call transcript or a press release.
Get AZR alertsAbout Julie Saiki, Ph.D.
Azora Therapeutics, Inc. (DE) reported in an 8-K filed October 28, 2026 that Julie Saiki, Ph.D. was appointed Chief Strategy Officer, effective October 28, 2026. Azora Therapeutics, Inc. (DE) is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Azora Therapeutics, Inc. (DE) includes Matthew Davidson (CEO), Matthew Davidson, Ph.D. (CEO), William B. Stilley (CEO) and 7 others.
“Effective as of the Effective Date, the Board appointed Julie Saiki, Ph.D. as the Company’s Chief Strategy Officer.”
Affiliation history
-
Current
2026-10-28–present
Company network
Leadership on record at Azora Therapeutics, Inc. (DE)
- Matthew Davidson CEO
- Matthew Davidson, Ph.D. CEO
- William B. Stilley CEO
- Kevin Schuyler Chairman
- Celia Economides CFO
- Vinay K. Shah CFO
- Cary Claiborne COO, Board Member
- Cary J. Claiborne COO, Board Member
- Tony Goodman COO
- Dr. Jack Reich Board Member